wk7 lec1

Ageing of the Human Eye

Introduction

  • The lecture reviews age-related changes in the human anterior eye (including adnexa) and posterior eye and optic nerve.
  • Key questions addressed:
    • Do our eyes change over a lifetime and why?
    • What are the main (normal) eye ageing changes observed?
    • Is normal eye ageing different to age-related eye disease?
    • Do all people age at the same rate?

Ageing vs. Disease

  • Ageing is not the same as disease, but the incidence of many diseases increases with age.
  • Ageing can increase the vulnerability or risk for disease development.
  • Age is an important risk factor for eye diseases such as AMD, glaucoma, or diabetic retinopathy.
  • Features of age-related retinal diseases include:
    • Disruption of retinal homeostasis.
    • Low-grade chronic inflammation (para-inflammation).
  • The prevalence of age-related diseases is increasing, leading to age-related vision loss and visual impairment.

Prevalence of Vision Impairment

  • The prevalence of vision impairment increases with ageing.

Summary of Ageing Changes in the Eye

Pupil
  • Miosis (pupil becomes smaller) and less reactive.
  • Clinical manifestations: glare, reduced contrast sensitivity, extended depth of field.
Upper Eyelid
  • Blepharoptosis (drooping eyelid), dermatochalasis (excess eyelid skin).
  • Clinical manifestation: disorders of the upper visual field.
Lens
  • Increased density.
  • Clinical manifestations: glare, decreased contrast sensitivity, hue perception changes, presbyopia.
Vitreous
  • Changes in collagen fibrils and HA (hyaluronic acid) components.
  • Clinical manifestations: flashes and floaters.
Retina
  • RNFL (Retinal Nerve Fiber Layer) decline, neuronal cell loss and degeneration.
  • Clinical manifestation: decline in visual function.
Extraocular Muscle
  • Mechanical imbalance, alterations in collagen and elastin.
  • Clinical manifestation: binocular imbalance.
Optic Nerve
  • Decrease in the number of optic nerve axons.
  • Clinical manifestation: visual field changes.
Cornea
  • Decrease in nerve fiber density, metabolism, endothelial cells.
  • Clinical manifestations: dry eye, decreased sensitivity.
Trabecular Meshwork
  • Increased pigmentation.
  • Clinical manifestation: increased IOP (intraocular pressure).
Macula
  • Macular microcirculation decrease.
  • Clinical manifestation: development of SRNVM (Subretinal Neovascular Membrane).
Visual Cortex
  • Increased density, changes in temporal processing in areas 17 and 18, cortical processing changes in areas V1 and V2.
  • Clinical manifestations: decrease in stereopsis, oculomotor accuracy, dynamic visual acuity, processing speed, contrast sensitivity, binocular summation.

Ocular Adnexa and Surrounds

  • Orbital orbicularis: forceful eye closing.
  • Palpebral orbicularis: gentle eyelid closing (e.g., voluntary winking, involuntary spontaneous blinking to refresh tear film).
  • Ciliary orbicularis: eyelid margin (cilia = hair-like).

Ageing Eyelids and Adnexal Tissue

  • Advanced loss of tone and elasticity leads to 'saggy, baggy' eyelids.
  • Involutional changes in skin, orbicularis and levator muscles, tarsus and canthal tendons cause age-related laxity of the eyelids.
  • Horizontal laxity of canthal tendons, attenuation or disinsertion of eyelid retractors, and overriding by pre-septal orbicularis oculi muscle cause 'drooping eyelids'.
  • Commonly involved in age-related eyelid disorders such as lower lid entropion and ectropion.
  • Involution: shrinkage of an organ in old age or when inactive.

Effects of Eyelid Ageing

  • Associated problems such as dry eye, redness, irritation, inflammation (related to eyelid ectropion or entropion).
  • Eyelid 'drooping' may impact vision and visual fields.
  • Example: Visual field defects caused by lid dermatochalasis, which improve after taping up the upper lid.

Ocular Surface Health and Ageing

Tear Film
  • Normal tear film thins between blinks.
  • Tear film volume is small (approximately 8mu8 mu unstimulated).
  • Average tear volume turnover rate: 16% per minute.
  • Osmolarity: average approximately 300mOsm/L300 {mOsm/L}.
  • pH approximately 7 to 7.4.
Ocular Surface Changes
  • Ocular surface abnormalities increase with age (Arita et al., 2008).
  • Ageing leads to changes in meibum composition, resulting in 'opaque' meibum (Sullivan et al., 2006).
  • Decreased nerve density leads to decreased sensitivity (cornea, conjunctiva?).
  • Decreased levels of sex hormones affect tear film quality.
  • Decreased lacrimal gland secretion.
  • Reduced/changed ocular surface immune responsiveness with ageing (Galleti and de Paiva, The Ocular Surf 2021: 20,139-162).
  • Possible outcomes: lower eyelid redness and telangiectasia, irregular eyelashes & ocular surface problems, gland openings affected, dry sore eyes.
Major Age-Related Changes: Ocular Surface
  • Lacrimal gland secretion diminishes, and the composition of secretion changes. Gland inflammation and ductal fibrosis have been reported.
  • Meibomian glands decrease in number, and their ducts keratinize, causing occlusion. Lipid secretions change in character.
  • Changes in tear composition and amount occur with age.
  • Conjunctival wrinkles (conjunctivochalasis) develop nasally and temporally.
Immune Response of Mucosal Ocular Surface
  • Age-related changes affect immune components of the ocular surface (Galleti and de Paivia, 2021).

Corneal Ageing

Corneal Sensitivity
  • Corneal sensitivity decreases with age.
  • Central and peripheral cornea are affected.
  • Nerve fiber length and density decrease with age (Chin et al., Cornea. 2024 43: 409-418; confocal microscopy).
Ageing Descemet’s Layer
  • Descemet’s layer: basement membrane produced by endothelial cells.
  • Thickness increases with age: approximately 5mum5 mu m at birth, increasing to approximately 20mum20 mu m in adults.
  • Anterior lamina = banded zone (prenatal) approximately 3mum3 mu m.
  • Posterior lamina = non-banded zone (produced during life).
  • Peripheral cornea: age-related local thickenings in Descemet’s (Hassall-Henle bodies; 'bumps').
Ageing Cornea: Endothelium
  • Cell density decreases over life (approximately 4,000 cells/mm2mm^2 at birth, approximately 2,000 cells/mm2mm^2 at age 80 years).
  • <1,000 endothelial cells/mm2mm^2 results in cornea swelling and cloudiness.
  • Cell stress manifests as changes in endothelial cell shape (polymegethism) & polymorphism (pleomorphism).
  • Endothelial cell density decreases with age, disease, trauma, surgery (e.g., IOL), and contact lens wear.
Corneal Shape
  • Cornea flattens, decreasing refractive power, and decreases astigmatism in the vertical direction.
  • Corneal diameter increases after birth: average horizontal corneal diameter at birth is approximately 9.5 to 10.5 mm, and in adults approximately 12.0 mm.
Corneal Ageing Summary
  • Cornea (and ocular) astigmatism changes from with-the-rule to against-the-rule astigmatism (>- approximately 50 years).
  • Transparency (central) remains normal, dependent on endothelial density.
  • Decreased corneal sensitivity.
  • Increased Descemet’s membrane thickness.
  • Decreased endothelial cell density.

Anterior Chamber Depth and Ageing

  • Decreased anterior chamber depth with age (Atchison et al. 2010).
  • Anterior chamber shallows with age, and lens thickness increases.

Ageing of the Iris and Pupil

Functions of the Iris
  • Control light reaching the retina.
  • Optical effects (reduce aberrations by limiting ‘peripheral’ light).
  • Depth of focus at near.
Normal Human Iris Trivia
  • Size: approximately 2 to 9 mm diameter.
  • Regulated by sympathetic and parasympathetic systems.
  • Physiological anisocoria (different pupil sizes): 0.3 to 0.4mm in 50% of the population; > 1.5mm is due to ‘disease’.
  • Decentered nasally by 0.5mm.
  • Hippus (physiological tremor).
Ageing and Pupil Size
  • Pupil size is determined by age, level of retinal illumination (light reflex), emotional factors (e.g., pain, pleasure, fear), and accommodation and/or convergence (near reflex).
  • With age, pupils:
    • become smaller and less reactive to light.
    • are more difficult to dilate.
    • increase depth of focus/field.
    • increase diffractive effects.
    • are smaller, reducing fundus (retinal) illumination and 'view'.
Pupil Size Decrease with Age
  • Pupil size decreases with age, as shown in a study with n = 1862 participants.

Ageing Human Lens

Lens Features
  • Ellipsoid shape.
  • Biconvex: posterior surface with a steeper curve radius (rant approximately 10 mm; rpost approximately 6 mm; radius).
  • Gradient refractive index: increases from the surface inwards to the center.
  • Refractive index: cortex = 1.38 vs nucleus = 1.41.
  • Anterior pole; Lens thickness approximately 4mm; Equatorial diameter ~10mm; Equator and Posterior pole.
Physical Features of Lens Ageing
  • Lens thickness increases and lens equatorial diameter increases with age.
Lens Equivalent Refractive Index and Power
  • Lens equivalent refractive index and lens equivalent power decrease with age (Atchison et al., 2008).
Lens Stiffness
  • Lens stiffness increases with age.
Lens Spectral Transmission
  • Age-related loss in retinal illumination: decreasing light transmission + smaller pupil area.
  • Reasonably uniform % loss per decade.
  • Most impact on shorter violet (400-440 nm) and blue (440-500 nm) wavelengths.
Redox Biology of the Eye Lens
  • Young age: lens glutathione mostly in reduced form.
  • GSH levels are maintained by an active glutathione redox cycle that ensures a high GSH:GSSG ratio.
  • Recycling GSSG involves enzymes (e.g., glutathione reductase).
  • Aged and cataractous lenses have altered GSH/GSSG ratios.
Lens Chemical Barrier
  • A 'chemical lens barrier' forms at the cortex/nucleus interface around ~40 years ('middle-age'); it is an internal 'chemical barrier' to the diffusion of small molecules (Sweeney and Truscott, 1998; Moffat et al.,1999).
  • Consequences:
    • Impedes the flow of molecules such as antioxidants (e.g., GSH) into the nucleus, predisposing the lens nucleus to oxidation.
    • Unstable molecules, once inside the barrier, are present much longer in the lens nucleus.
Location of Active Metabolism in the Lens
  • Arrows indicate the direction of diffusion of glutathione (GSH) from active cells to metabolically inactive lens nucleus cells.
  • When glutathione is oxidized to GSSG in the lens nucleus, it diffuses down the concentration gradient in the opposite direction, towards the lens surface.
  • Synthesis and recycling of GSH decreases with age, leading to progressive loss of nuclear GSH and a rise in GSSG.
Lens UV-Filter Proteins
  • UV-filter proteins in the lens: low-molecular weight compounds that absorb UV radiation from 300 to 400 nm.
  • Can protect the lens (and the retina) from UVR-induced damage, but proteins degrade over time and with age.
  • With age, the ratio of primary to secondary UV filter proteins reduces from approximately 10:1 to 2:1.
Ageing of the Lens Summary
  • Physical and biomechanical changes:
    • Central thickness and equatorial lens diameter increase (lens fibers added over life).
    • Lens power decreases.
    • Anterior capsule thickness increases.
    • Lens stiffness increases.
    • Colour changes (yellowing related to changes in UV-barrier properties).
    • Refractive index across the lens changes; equivalent refractive index decreases.
  • Molecular changes:
    • Life-long protein changes: post-translational modifications accumulate in the human lens with age (from birth - not easy to quantify).
    • Lens proteins become progressively insoluble over time.
    • Lens ‘barrier’ forms around ~40 years, limiting GSH (reduced) moving into the nucleus, increasing nucleus oxidative stress (GSH -> GSSG).
    • UV-barrier proteins 'change’ with age and lens yellows; filters out shorter wavelengths of light.
  • Optical effects: light scattering + light absorption and transmission effects change with age (wavelength-related).

Ciliary Muscle and Ageing

  • Ciliary muscle maximum width increases significantly with age (Sheppard and Davies, 2011).
  • During accommodation, changes to ciliary muscle thickness and length remained constant throughout life (Sheppard and Davies, 2011).
  • During accommodation in the aged eye, ciliary muscle sectors behave similarly, suggesting accommodation is equal for the different sectors (Dominguez-Vincent et al., 2019).
  • Accommodative change in ciliary muscle diameter seems unaffected by ageing or IOL (intraocular lens) implantation.
  • Morphological changes do not seem to affect ciliary muscle contracting during accommodation, even for presbyopes, supporting a lenticular model of presbyopia development.

Ageing and Presbyopia

  • Presbyopia = loss of ability to focus light directly onto the retina at near.
  • Caused by age-related changes in the lens, lens capsules, lens zonules, ciliary muscle, and choroid.
Presbyopia Aetiologies or Causes?
  • Ageing lens is harder to deform or change shape (mechanical) + changes in lens size and shape that affect forces generated by zonules (geometrical).
  • Ciliary muscle theory: changes in tissue with ciliary muscle replaced by connective tissue, but the force of contraction is likely maintained with age.
  • Zonule theory: seems to change little with age.
  • Lens capsule theory: the anterior capsule thickens with age, less elastic, and does not change curvature so easily.
  • Lens nucleus stiffness: central lens power independent of ageing nucleus stiffness (Schachar et al., 2025 PLoS One) – unlikely presbyopia aetiology.
  • A combination of the various ‘theories’?

Ageing: Ciliary Body and Aqueous Humour Dynamics

  • Aqueous humour: age-related decrease in the rate of production by 15 to 35% between 20 to 70 years (Gabelt et al., 2005) + increase in trabecular meshwork (TM) outflow resistance with age.
  • Progressive decrease in human TM cell count with age (Alvarado et al. 1984; Grierson et al., 1982; Gabelt et al. 2005).
  • Increase in cells detaching from TM, 20 years (1.2 million cells), 80 years (~500,000 cells); decrease of 12,000 cells/year (Gabelt et al. 2005); 0.56% per year (Alvarado et al. 1984).
  • Grierson et al. (1982) reported a decline from 763,000 TM cells at 20 years to 403,000 at 80 years; loss of 6000 cells/year. (VISN2111)